Skip to main content

Table 4 EZ-ALBI and ALBI grade change after TACE

From: Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

Grade change (N = 142)

EZ-ALBI, N (%)

ALBI, N (%)

Improving grade

6 (4.2%)

6 (4.2%)

Same grade

94 (66.2%)

92 (64.8%)

Worsening grade

42 (29.6%)

44 (31.0%)

  1. ALBI Albumin-bilirubin, EZ-ALBI Easy albumin-bilirubin, N Number
Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us